Some people report changes in energy levels after stopping
doi: 10.1093/rheumatology/kep287 66 GladmanDNashPGotoHBirtJLinC-YOrbaiA-Met al
Clinical trials are still needed to confirm the benefit
The debilitating, slow damage created by high levels of blood sugar (glucose) destroys everything from your blood vessels to your eyes, kidneys, and nerves over time due to oxidative stress (remember the free radicals or reactive oxygen species (ROS)?)
The LEADER trial enrolled patients with T2DM and high cardiovascular risk, defined as established CVD (81%) or age 60 years with at least one risk factor, and showed that liraglutide significantly reduced the incidence of 3-point major adverse cardiovascular events (MACE) (i.e., CV death, non-fatal myocardial infarction, non-fatal stroke) by 13% compared to placebo (HR 0.87
The correct dosage varies depending on whether you are maintaining adequate levels or treating a deficiency